Back to Search
ANDREW ZOLOPA, M.D.
M.D.
Infectious Disease Physician
NPI: 1447264130Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
G57563(CA)
Research & Publications (20)
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial.
PMID 19440326·PLoS One·2009
4-observational
Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
PMID 16921474·J Infect Dis·2006
6-review
Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).
PMID 15937768·Clin Infect Dis·2005
4-observational
Maintaining reduced viral fitness and CD4 response in HIV-infected patients with viremia receiving a boosted protease inhibitor.
PMID 19191657·Clin Infect Dis·2009
4-observational
Hepatotoxicity and gastrointestinal intolerance when healthy volunteers taking rifampin add twice-daily atazanavir and ritonavir.
PMID 19194314·J Acquir Immune Defic Syndr·2009
3-trial
Initiation of antiretroviral therapy in the hospitalized patient with an acute AIDS-related opportunistic infection and other conditions: no time to lose.
PMID 19358776·Curr HIV/AIDS Rep·2009
6-review
Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial.
PMID 18996868·Am J Clin Nutr·2008
4-observational
Initiatives for developing and comparing genotype interpretation systems: external validation of existing systems for didanosine against virological response.
PMID 18598191·J Infect Dis·2008
8-other
Virologic response to lopinavir-ritonavir-based antiretroviral regimens in a multicenter international clinical cohort: comparison of genotypic interpretation scores.
PMID 18710915·Antimicrob Agents Chemother·2008
4-observational
Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study.
PMID 18809940·Antimicrob Agents Chemother·2008
3-trial
Antiretroviral rounds. Immediate ART after an OI: are we there yet?
PMID 18841619·AIDS Clin Care·2008
8-other
Integrase inhibitors: a clinical review of raltegravir and elvitegravir.
PMID 18953272·J HIV Ther·2008
6-review
Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.
PMID 17570119·J Infect Dis·2007
3-trial
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.
PMID 17576825·Antimicrob Agents Chemother·2007
8-other
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
PMID 17109338·J Infect Dis·2006
3-trial
The effect of diagnosis with HIV infection on health-related quality of Life.
PMID 16411032·Qual Life Res·2006
8-other
The study of fat redistribution and metabolic change in HIV infection (FRAM): methods, design, and sample characteristics.
PMID 16524955·Am J Epidemiol·2006
4-observational
Case files from Stanford University Medical Center: the initial presentation of HIV-1 infection--where public and personal health meet.
PMID 16915154·MedGenMed·2006
5-case
N88D facilitates the co-occurrence of D30N and L90M and the development of multidrug resistance in HIV type 1 protease following nelfinavir treatment failure.
PMID 17209774·AIDS Res Hum Retroviruses·2006
8-other
Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers.
PMID 16084849·Clin Pharmacol Ther·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR
STANFORD, CA 94305 - Phone
- (650) 723-4000
Quick Facts
- NPI
- 1447264130
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile